istock-842659810_mirceax-1
mirceax / iStockphoto.com
10 October 2018Americas

Conference preview: Life Sciences IP Due Diligence 2018

American Conference Institute is pleased to announce that its 2nd Annual Summit on Life Sciences IP Due Diligence will return to the world’s largest life sciences hub, Boston.

This premier event, featuring leading life sciences practitioners, will provide corporate and IP counsel as well as business development executives with best practices for designing and conducting successful and cost-effective due diligence analyses.

“The conference faculty features industry leaders from more than 20 pharmaceutical and biotech companies.”

Philip Johnson, former senior vice president of IP policy and strategy at Johnson & Johnson, and retired Chief Judge Paul Michel of the US Court of Appeals for the Federal Circuit are set to engage in a fireside chat on “Global Factors Influencing IP Due Diligence” at the event.

Speaking together on this important topic, they commented: “Advance assessment of freedom to operate and the need to secure patents and possibly licences in both foreign markets and the US is so critical to all parties active in health science industries that IP diligence must be everyone’s top priority.”

In addition to Johnson and Michel, the conference faculty features industry leaders from more than 20 pharmaceutical and biotech companies, and leading attorneys from more than a dozen top law firms. Confirmed speakers include representatives from CRISPR Therapeutics, Eisai, Merck & Co, Novartis Pharmaceuticals and more.

Don’t miss this opportunity to benchmark your IP diligence strategies with top industry representatives.

Register with our exclusive discount code P10-999-LSPR19 to save 10% of the ticket cost for the main conference. Call 1-888-224-2480 or visit us at www.americanconference.com/IPDueDiligence